Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities.

World J Gastroenterol · 2017 · PMC5743499 · PMID 29307988

Europe PMC DOI

hedged sentence

0.4160

closest p · 8.3× alpha

0.4160

boldest claim

The sentences

did not reach statistical significanceP = 0.416not close (p > 0.1)

Procalcitonin displayed good performance for discriminating bacterial gastroenteritis from IBD [area under the curve (AUC), 0.727; P < 0.001], and its serum levels were higher between patients with active or inactive IBD, although such difference did not reach statistical significance (0.052 ng/mL vs 0.003 ng/mL, P = 0.416).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.